Clinical trial
Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
NCT00630708 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 29, 2008
- Completion date
- March 31, 2014
- Enrollment
- 309 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.